CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma
Journal of Cellular Immunotherapy · 2016-03 · 2 (1) · 28-35
DOI: 10.1016/j.jocit.2014.11.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Immunotherapy, 2016-03. Verfasst von Bo Guo und 9 weiteren Autor:innen. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, the National Basic Science and Development Programme of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- the National Natural Science Foundation of China
- the National Basic Science and Development Programme of China
Zitieren
APA
Guo, B., Chen, M., Han, Q., Hui, F., Dai, H., Zhang, W., Zhang, Y., Wang, Y., Zhu, H., & Han, W. (2016). CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma. Journal of Cellular Immunotherapy, 2(1), 28-35. https://doi.org/10.1016/j.jocit.2014.11.001
Vancouver
Guo B, Chen M, Han Q, Hui F, Dai H, Zhang W, et al. CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma. Journal of Cellular Immunotherapy. 2016;2(1):28-35. doi:10.1016/j.jocit.2014.11.001
BibTeX
@article{Guo2016,
author = {Guo, Bo and Chen, Meixia and Han, Qingwang and Hui, Fan and Dai, Hanren and Zhang, Wenying and Zhang, Yajing and Wang, Yao and Zhu, Hongli and Han, Weidong},
title = {CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma},
journal = {Journal of Cellular Immunotherapy},
year = {2016},
volume = {2},
number = {1},
pages = {28--35},
doi = {10.1016/j.jocit.2014.11.001}
}
EUVIMED